安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Prolia® (denosumab) for Postmenopausal Osteoporosis
Prolia ® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture
- Denosumab (subcutaneous route) - Side effects uses
Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men It is given when other medicines cannot be used or after other medicines did not work well
- Prolia: A Biannual Injection for Osteoporosis and Bone Loss . . . - WebMD
Prolia is an injection given every 6 months to treat osteoporosis in men, postmenopausal women, and people who take corticosteroid medicines who are at high risk for fractures
- Prolia Injection (Denosumab): Uses Side Effects
Prolia® injection is a brand of denosumab, which treats osteoporosis Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures
- 7 Side Effects of Prolia to Know Before Taking It - GoodRx
Prolia (denosumab) is a twice-yearly injection for osteoporosis While well-tolerated, it does have some possible side effects Common Prolia side effects include aches and pains in your muscles and bones These are typically mild and manageable at home
- Denosumab - Wikipedia
Denosumab, sold under the trade name Prolia among others, as well as many biosimilars, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone [66][67]
- Prolia (Denosumab Injection): Side Effects, Uses, Dosage . . . - RxList
Prolia (Denosumab Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources
- Prolia (denosumab) Label - Food and Drug Administration
Prolia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or
|
|
|